Skip to content

Clinical trials

Phase 2 Blood Platelet Disorders trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Blood Platelet Disorders Phase: Phase 2 Clear all

9 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20061
20091
20102
20131
20141
20211
20221

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated4
Completed3
Unknown status1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Shionogi2
Ayman Saad1
Fondazione IRCCS Policlinico San Matteo di Pavia1
Royal Brompton & Harefield NHS Foundation Trust1
Sanofi1
Sierra Oncology LLC - a GSK company1
The First Affiliated Hospital of Soochow University1
Weill Medical College of Cornell University1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Blood Platelet Disorders9
Hematologic Diseases3
Purpura, Thrombocytopenic, Idiopathic3
Thrombocytopenia3
Blood Coagulation Disorders2
Purpura, Thrombotic Thrombocytopenic2
Bone Marrow Diseases1
Heart Defects, Congenital1
Hemorrhagic Disorders1
Myeloproliferative Disorders1

Trials

Showing 26 to 9 of 9. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.